Specializing in diabetes management, Loncom Pharma's Hypoglycemic APIs category offers a range of active ingredients essential for the development of antidiabetic drugs. These APIs help in lowering blood glucose levels, catering to the needs of patients with type 2 diabetes.
Shandong Loncom Pharmaceutical Co., Ltd is founded in 2012, located in Qihe Economic Development Zone, Shandong Province, with a registered capital of 60 million yuan.
